CK-19 Monoclonal Antibody

CK-19 Monoclonal Antibody

Introducing the CK-19 Monoclonal Antibody, a cutting-edge scientific innovation designed to revolutionize the field of cancer research and diagnostics. This meticulously crafted product is meticulously engineered to detect and target cytokeratin 19 (CK-19), a protein marker commonly found in various types of cancer cells.

The CK-19 Monoclonal Antibody boasts exceptional specificity and sensitivity, enabling accurate identification and localization of CK-19 expression in tissue samples. Its high affinity for CK-19 ensures reliable and precise results, facilitating the advancement of cancer diagnosis, prognosis, and treatment strategies.

Crafted with utmost precision and adhering to stringent quality control measures, this antibody guarantees consistent and reproducible performance, making it an indispensable tool for researchers, clinicians, and pathologists alike. Its exceptional stability and long shelf life ensure optimal functionality and reliability, even in the most demanding laboratory settings.

The CK-19 Monoclonal Antibody is compatible with a wide range of immunohistochemical techniques, including immunofluorescence, immunoprecipitation, and Western blotting, allowing for versatile applications in various experimental setups. Its user-friendly nature and straightforward protocols make it accessible to both seasoned professionals and newcomers in the field.

With the CK-19 Monoclonal Antibody, researchers and medical practitioners can unlock new insights into cancer biology, unravel intricate molecular mechanisms, and pave the way for personalized therapeutic interventions. Embrace this groundbreaking tool and embark on a journey towards enhanced precision and efficacy in cancer research and diagnostics.